Document is current
Any future updates will be listed below
-
Authors
Rapado-González, Óscar
Salta, Sofia
López-López, Rafael
Henrique, Rui
Suárez-Cunqueiro, María Mercedes
Jerónimo, Carmen
-
Funding
Funding for this research was provided by:
Axencia Galega de Innovacion (GAIN), Programa de ayudas a la etapa posdoctoral de la Xunta de Galicia (IN606B-2022/007)
Consello Social Universidade de Santiago de Compostela (2021-PU007)
Instituto Português de Oncologia do Porto (CI-IPOP-74-2016)
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 25 July 2024
First Online: 13 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: All authors have read the journal's policy on disclosure of potential conflicts of interest and report the following: Rafael López López has received honoraria for participation in Advisory Boards from Roche, AstraZeneca, Merck, Merck Sharp & Dohme, Bayer, Bristol-Myers Squibb, Novartis, Janssen, Lilly, Pfzer, and Leo; travel, accommodations, and expenses from PharmaMar, Roche, Bristol Myers Squibb, and Pierre Fabre; research funding from Roche and Merck; and is co-founder and shareholder in Nasasbiotech, S.L., Mtrap Inc. The remaining authors have no conflicts of interest to declare.
